RELIEF THERAPEUTICS HOLDING AG

RLFTF OTC

cardonajuanc

Anticipating some positive news from RLFTF's and further FDA approval for it's Aviptadil. ABCDE Triagle wave approaching completion, confirmed by Williams Alligator, and Fib Retracement A bounced off 0.382 level C bounced off 0.5 level Look for E confirmation off 0.618 level Should price exit the triangle formation, setting target @ $1.2

OTCMarketsExpert

Company Details RELIEF THERAPEUTICS Holding AG is a clinical stage biotechnology company. It engages in the development and licensing of its portfolio of medicinal products candidates. Its products include aviptadil, for respiratory indications such as sarcoidosis and pulmonary hypertension; and atexakin alfa, for the treatment of diabetic neuropathy. The company...

01:57

satish-gaire

This is a SWISS company trading in OTC but this is a REAL company with REAL DRUG. So They have an ED medication ( Aviptadil ) that hospitals might use for COVID patients with respiratory Failure They are on "FAST TRACK" For FDA Approval .20 cents is a good buy. I got in at .18 and sold and bought several times to make a profit today. but I am still in...

HotCharts

Relief Therapeutics Holding AG, a clinical stage biotechnology company, engages in developing treatment solutions for indications related to diabetic complications and respiratory diseases. The company is developing aviptadil, which has completed Phase II clinical trial for the treatment of sarcoidosis, an orphan pulmonary disease, as well as pulmonary...